Bioshares Fundamentals

BBP -  USA Etf  

USD 47.13  1.03  2.14%

Bioshares Biotech Products fundamentals help investors to digest information that contributes to Bioshares Biotech's financial success or failures. It also enables traders to predict the movement of Bioshares Etf. This fundamental analysis module provides a way for investors to measures Bioshares Biotech's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioshares Biotech etf. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bioshares Fundamentals 

 
Refresh

Bioshares Price to Earning Analysis

Bioshares Biotech's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
More About Price to Earning | All Equity Analysis

Current Bioshares Biotech Price to Earning

    
  18.03 X  
Most of Bioshares Biotech's fundamental indicators, such as Price to Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioshares Biotech Products is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition

Bioshares Biotech Price to Earning Component Assessment

Based on the latest financial disclosure, the price to earning indicator of Bioshares Biotech Products is roughly 18.03 times. This is much higher than that of the Virtus family and significantly higher than that of the Health category. The price to earning for all United States etfs is notably lower than that of the firm.

Bioshares Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bioshares Biotech's current stock value. Our valuation model uses many indicators to compare Bioshares Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioshares Biotech competition to find correlations between indicators driving Bioshares Biotech's intrinsic value. More Info.
Bioshares Biotech Products is second largest ETF in price to earning as compared to similar ETFs. It is second largest ETF in price to book as compared to similar ETFs fabricating about  0.09  of Price to Book per Price to Earning. The ratio of Price to Earning to Price to Book for Bioshares Biotech Products is roughly  10.86 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bioshares Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bioshares Biotech's Etf . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioshares Biotech's earnings, one of the primary drivers of an investment's value.

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Fund Asset Allocation for Bioshares Biotech

The fund consists of 97.81% investments in stocks, with the rest of investments allocated between various types of exotic instruments.
 Value 
      Instrument Type 

Bioshares Fundamentals

About Bioshares Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioshares Biotech Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioshares Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioshares Biotech Products based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Bioshares Biotech is traded on NYSEArca Exchange in the United States.

Bioshares Biotech Investors Sentiment

The influence of Bioshares Biotech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bioshares. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioshares Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioshares Biotech's short interest history, or implied volatility extrapolated from Bioshares Biotech options trading.

Current Sentiment - BBP

Bioshares Biotech Investor Sentiment

Greater number of Macroaxis users are currently bullish on Bioshares Biotech Products. What is your opinion about investing in Bioshares Biotech Products? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Bioshares Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioshares Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioshares Biotech will appreciate offsetting losses from the drop in the long position's value.

Bioshares Biotech Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bioshares Biotech and Biotechnology Index NYSE. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Bioshares Biotech Piotroski F Score and Bioshares Biotech Altman Z Score analysis. Note that the Bioshares Biotech information on this page should be used as a complementary analysis to other Bioshares Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Bioshares Etf analysis

When running Bioshares Biotech price analysis, check to measure Bioshares Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioshares Biotech is operating at the current time. Most of Bioshares Biotech's value examination focuses on studying past and present price action to predict the probability of Bioshares Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioshares Biotech's price. Additionally, you may evaluate how the addition of Bioshares Biotech to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Bioshares Biotech is measured differently than its book value, which is the value of Bioshares that is recorded on the company's balance sheet. Investors also form their own opinion of Bioshares Biotech's value that differs from its market value or its book value, called intrinsic value, which is Bioshares Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioshares Biotech's market value can be influenced by many factors that don't directly affect Bioshares Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioshares Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioshares Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioshares Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.